Lexeo Therapeutics (LXEO) Accumulated Expenses (2022 - 2023)
Historic Accumulated Expenses for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $11.8 million.
- Lexeo Therapeutics' Accumulated Expenses changed N/A to $11.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $11.8 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2022, which is N/A changed from last year.
- Per Lexeo Therapeutics' latest filing, its Accumulated Expenses stood at $11.8 million for Q3 2023.
- In the past 5 years, Lexeo Therapeutics' Accumulated Expenses ranged from a high of $11.8 million in Q3 2023 and a low of $6.4 million during Q4 2022